B-Cell Non-Hodgkin’s Lymphoma: Epidemiology Forecast to 2027

2019-06-25
Price :
Published : Jun-2019
No. of Pages : 44

B-Cell Non-Hodgkin’s Lymphoma: Epidemiology Forecast to 2027

Summary

Non-Hodgkin’s lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the patient’s immune system is affected by the uncontrollable growth of malignant white blood cells, resulting in the body’s inability to fight infections and other diseases. NHL accounts for 90% of all malignant lymphomas. NHL is one of the most prevalent hematologic cancers in adults and is more commonly diagnosed in developed countries. B-cell lymphomas are the most common form of NHL diagnosed in developed countries, making up approximately 80-85% of NHL cases in the US.

GlobalData epidemiologists used age- and sex-specific diagnosed incidence and prevalence rates to forecast the diagnosed incident and prevalent cases, taking into account the significant relationship between age and B-cell NHL incidence and prevalence. GlobalData epidemiologists applied country-specific incidence and prevalence rates of B-cell NHL, wherever available, to each country’s population to obtain the number of estimated diagnosed incident and prevalent cases.

The following data describes epidemiology of B-cell NHL cases. In 2017, the 7MM had 154,245 diagnosed incident cases of B-cell NHL. This is expected to increase to 183,052 diagnosed incident cases by 2027, at an Annual Growth Rate (AGR) of 1.87%. This increase is partly attributed to the moderately rising trend in incidence in the 7MM, combined with underlying demographic changes in the respective markets. In the 7MM, DLBCL was the most common subtype of B-cell NHL, followed by FL, MZL, and MCL. The US had the highest number of diagnosed incident and diagnosed prevalent cases of B-cell NHL. The development of more effective therapies, particularly for elderly patients, would improve survival and increase disease prevalence.

Scope

– The B-cell Non-Hodgkin’s Lymphoma (B-cell NHL) Epidemiology Report provides an overview of the risk factors and global trends B-Cell Non-Hodgkin’s Lymphoma in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
– This report also includes a 10-year epidemiological forecast for the following segmentations in ages 18 years and older across the 7MM: diagnosed incident cases of B-cell NHL; diagnosed prevalent cases of B-cell NHL; and diagnosed incident and prevalent cases of B-cell NHL types such as Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Marginal Zone Lymphoma (MZL), and Mantle Cell Lymphoma (MCL) in these markets. Additionally, diagnosed incident cases of DLBCL, FL, MZL, and MCL are segmented according to Ann Arbor staging (stage I -IV). Diagnosed incident cases of FL based on grade (Grades 1-3) is also provided in this report.
– The B-cell NHL epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
– The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The B-cell NHL Epidemiology report will allow you to –
– Develop business strategies by understanding the trends shaping and driving the global B-cell NHL market.
– Quantify patient populations in the global B-cell NHL market to improve product design, pricing, and launch plans.
– Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for B-cell NHL therapeutics in each of the markets covered.
– Understand magnitude of B-cell NHL market by subtypes such as DLBCL, FL, MZL, and MCL.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Hemostasis Rapid Tests & Point of Care (POC) – Medical Devices Pipeline Assessment, 2019

Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019" provides an overview of Hemostasis Rapid Tests & Point of Care (POC) currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Rapid Tests & Point of Care (POC) pipeline products. This ......
$2500

Hematology Tests – Medical Devices Pipeline Assessment, 2019

Hematology Tests - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Hematology Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Hematology Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's te......
$4000

Urine Analysis – Medical Devices Pipeline Assessment, 2019

Urine Analysis - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Urine Analysis - Medical Devices Pipeline Assessment, 2019" provides an overview of Urine Analysis currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urine Analysis pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of in......
$2500

Organ Function Assays – Medical Devices Pipeline Assessment, 2019

Organ Function Assays - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Organ Function Assays - Medical Devices Pipeline Assessment, 2019" provides an overview of Organ Function Assays currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Organ Function Assays pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary researc......
$2500

Female Fertility Rapid Tests – Medical Devices Pipeline Assessment, 2019

Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Female Fertility Rapid Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Female Fertility Rapid Tests pipeline products. This report is prepared using data sourced from in-house databases, s......
$2500

Anemia Tests – Medical Devices Pipeline Assessment, 2019

Anemia Tests - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Anemia Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Anemia Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Anemia Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry ex......
$2500

Immunoglobulin E (IgE) Allergy Blood Tests – Medical Devices Pipeline Assessment, 2019

Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Immunoglobulin E (IgE) Allergy Blood Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunoglobulin E (IgE) Allergy Blood Tests pipeline products. This report i......
$2500

Bone Metabolism Assays – Medical Devices Pipeline Assessment, 2019

Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019" provides an overview of Bone Metabolism Assays currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Metabolism Assays pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary res......
$2500

Self Testing – Medical Devices Pipeline Assessment, 2019

Self Testing - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Self Testing - Medical Devices Pipeline Assessment, 2019" provides an overview of Self Testing currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Self Testing pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry ......
$2500

Central Nervous Systems Therapeutic Drug Monitoring – Medical Devices Pipeline Assessment, 2019

Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019" provides an overview of Central Nervous Systems Therapeutic Drug Monitoring currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Central Nervous Systems Therapeutic Drug Monitori......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy